InsidersTradesSigma
Follow the AstraZeneca PLC share price and the full management transaction log of the company, a listed equity based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, AstraZeneca PLC has recorded 62 insider filings. Market capitalisation: €2,532.6bn. The latest transaction was reported on 8 July 2026 (Attribution). Among the most active insiders: Pascal Soriot. The full history is openly available.
62
Insider Decl.
n/a
Thresholds
€27m
34 ops.
Buy Volume
€6m
7 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AstraZeneca PLC Buy (bullish), based on 3 analysts. Average price target: SEK 1,906.39.
39Σ signal
Fundamental score
Ranked 9,969 of 28,551 companies
59.0
score / 100
Value38
Quality80
FCF yld0.4%
Earn yld0.4%
EV/EBITDA·
ROE22%
Gross mgn82%
Net mgn17%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 July 2026
Declarations62 total
2 shares@ US$190.430.0000% mcap100.0% of flowOrdinary SharesSEC:0001104659-26-081807:0
1 sharesOrdinary SharesSEC:0001104659-26-074570:0
11,893 shares@ US$185.780.0001% mcap100.0% of flowOrdinary SharesSEC:0001104659-26-065693:0
18,359 sharesOutside a trading venueISIN GB0009895292RNS:9573813
18,359 shares0AktieISIN GB0009895292FI:csv-fdb5b74349479ecd7306
18,359 shares0Outside a trading venueISIN GB0009895292RNS:8e3ee29f-6561-4d4a-b4da-692ddc5ae612
101,495 shares0Outside a trading venueISIN GB0009895292RNS:5fe43de8-211a-4f46-a319-58e1412d1721
14,967 shares0Outside a trading venueISIN GB0009895292RNS:8c70f526-3786-4892-ae1d-1f3a0a1c0b8b-0
4,863 shares0Outside a trading venueISIN GB0009895292RNS:8c70f526-3786-4892-ae1d-1f3a0a1c0b8b-1
103,581 shares@ £152.4224.9% of flowOutside a trading venueISIN GB0009895292RNS:ec41145d-c505-49d2-abc9-012fd6a1ad10-0
42,393 shares@ £152.4224.4% of flowOutside a trading venueISIN GB0009895292RNS:ec41145d-c505-49d2-abc9-012fd6a1ad10-1
297 shares@ £134.96100.0% of flowLONISIN GB0009895292RNS:f867b9bb-9c95-49b8-aeb0-82c09eec3938
5,735 shares0Outside a trading venueISIN GB0009895292RNS:b1f89928-ed45-4270-b9a9-b03b2c441316-0
5,735 shares0Outside a trading venueISIN GB0009895292RNS:b1f89928-ed45-4270-b9a9-b03b2c441316-1
297 shares@ €134.960.0000% mcap100.0% of flowAktieISIN GB0009895292FI:A003U931-1
5,735 shares0AktieISIN GB0009895292FI:A003U857-1
5,735 shares0AktieISIN GB0009895292FI:A003U856-1
15,000 shares@ £0.88630.1% of flowXNASRNS:7029b505-424c-42d2-9967-fa51b8ebde1e
15,000 shares@ €88.63450.0006% mcap100.0% of flowDepåbevisISIN US0463531089FI:A003T664-1
136,537 shares0Outside a trading venueISIN GB0009895292RNS:5560c7d9-89da-4207-b4ed-572d14a3e03a
136,537 shares0AktieISIN GB0009895292FI:A003T466-1
9.074 shares@ €81.04990.0000% mcap100.0% of flowDepåbevisISIN US0463531089FI:A003S640-1
0XNASRNS:5836319
9,563 shares@ £115.1175.5% of flowLONISIN GB0009895292RNS:5785143
9,563 shares@ €115.1170.0000% mcap15.1% of flowAktieISIN GB0009895292FI:A003R490-1
25 of 62 declarations
关于 AstraZeneca PLC
AstraZeneca PLC 是一家全球性制药公司，专注于药物的研发和商业化。该公司在斯德哥尔摩证券交易所 (XSTO) 上市。